Mary Reumuth | CFO |
Mark Iwicki | Chairman, President, CEO |
Kim Brazzell | Chief Medical Officer |
Todd Bazemore | COO |
Hongming Chen | Chief Scientific Officer |
David Maris | Wells Fargo |
Liana Moussatos | Wedbush Securities |
Yi Chen | H.C. Wainwright |
Good day, and welcome to Kala Pharmaceuticals Fourth Quarter 2018 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Following management's prepared remarks, a Q&A session will be held. And as a reminder, this call is being recorded. I would now like to turn the call over to Mary Reumuth, Chief Financial Officer for Kala Pharmaceuticals.